Cargando…
New dilemmas in small-cell lung cancer TNM clinical staging
BACKGROUND: Many patients with limited disease (LD) behave similarly to those with extensive disease (ED) from a prognostic point of view. On the other hand, a proportion of patients with ED small-cell lung cancer (SCLC) behave similarly to those with LD. PATIENTS AND METHODS: In this retrospective...
Autores principales: | Zarogoulidis, Konstantinos, Latsios, Dimitrios, Porpodis, Konstantinos, Zarogoulidis, Paul, Darwiche, Kaid, Antoniou, Nick, Hohenforst-Schmidt, Wolfgang, Eleftheriadou, Ellada, Boutsikou, Efimia, Kontakiotis, Theodoros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660153/ https://www.ncbi.nlm.nih.gov/pubmed/23700372 http://dx.doi.org/10.2147/OTT.S44201 |
Ejemplares similares
-
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013) -
Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer
por: Boutsikou, Eftimia, et al.
Publicado: (2013) -
Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013) -
Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice
por: Boutsikou, Efimia, et al.
Publicado: (2018) -
Predictive Value of 99MTC-hynic-toc Scintigraphy in Lung Neuroendocrine Tumor Diagnosis
por: Boutsikou, Efimia, et al.
Publicado: (2019)